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Abstract: The first asymmetric synthesis of (–)-morusimic acid D,
a 2,3-trans-2,6-cis-2-methyl-6-substituted piperidin-3-ol contain-
ing alkaloid is reported. The key steps are the reductive alkylation
of N,O-diprotected 3-hydroxyglutarimide, a stepwise reductive
alkylation, and an asymmetric aldol-type reaction using a modified
Evans chiral auxiliary.
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Substituted, hydroxylated piperidines constitute a class of
natural products exhibiting important bioactivities.1 As a
key structural feature shared by many piperidine alka-
loids, 2-methyl-6-substituted piperidin-3-ols with differ-
ent stereochemical patterns have been the targets of
numerous synthetic efforts, which have culminated in a
number of methods for the synthesis of these molecules.2–
8
 Because most of this class of piperidine alkaloids pos-
sess a 2,3-cis stereochemistry with either a 2,6-cis-stere-
ochemical pattern (A, Figure 1), or a 2,6-trans
stereochemistry pattern (B), much attention has been de-
voted to the construction of cis-2-methylpiperidin-3-ol
skeleton.3 Only a few methods are available for the syn-
thesis of trans-2-methylpiperidin-3-ols,4 although several
methods have been developed for the syntheses of struc-
turally related piperidine alkaloids prosophylline5 and mi-
cropine,6 quinolizidine alkaloids clavepictines7 and
pictamine,7a as well as decahydroquinoline alkaloid lepa-
din D.8 In 2002, two 2,3-trans-2,6-cis-2-methyl-6-substi-
tuted piperidin-3-ol containing alkaloids, morusimic acids
C (1) and D (2) were isolated from white ripened fruit of
M. alba grown in Turkey.9
In continuation of our studies on the development of pro-
tected 3-hydroxyglutarimide-based synthetic methodolo-
gy,10–12 we now report an application of this methodology
to the first asymmetric synthesis of morusimic acid D (2),
an alkaloid having a 2,3,6-trans,trans stereochemistry.
As displayed retrosynthetically in Scheme 1, both the C2
methyl group and the 2,3-trans stereochemistry were en-
visioned to be introduced by the reductive alkylation
method10,11 starting from the protected 3-hydroxyglutar-
imide 6.12 The C6 side chain with 2,6-cis stereochemistry
was considered to be accessible by another diastereoselec-
tive reductive alkylation method.13
The synthesis commenced with (R)-3-benzyloxy-1-(4-
methoxybenzyl)glutarimide [(R)-6],12 which was pre-
pared from D-glutamic acid following essentially the pro-
cedure described for its enantiomer (Scheme 2).12
For the reductive methylation, although our previous
study showed that the addition of methyl magnesium io-
dide (3 molar equiv) to (S)-3-hydroxyglutarimide deriva-
tive (S)-6 in THF at –78 °C yielded a diastereomeric
mixture of N,O-acetal 10 and its C6 adduct in 86:14 C2/
C6 regioselectivity, it was found that almost only the C2
addition product was obtained when undertaking the reac-
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tion in CH2Cl2 and at –20 °C. The subsequent reductive
dehydroxylation under ionic hydrogenolytic conditions14
(Et3SiH/BF3·OEt2, CH2Cl2, –78 °C to r.t.) furnished pre-
dominantly trans-11 (trans/cis = 92:8). Cleavage of the
N-(4-methoxybenzyl) group by treating (5R,6S)-11 with
ceric ammonium nitrate (CAN) in MeCN–H2O (3:1)15 at
room temperature gave lactam (5R,6S)-12 in 58% yield
(Scheme 2).
Next, we turned our attention to the introduction of the
chiral C6 side chain. To this end, another diastereoselec-
tive reductive alkylation method13 was adopted. Thus, lac-
tam 12 was first converted [(Boc)2O, Et3N, DMAP,
CH2Cl2, 24 h] to imide (5R,6S)-5, an activated form13b of
the former (Scheme 2). Reaction of Grignard reagent 1316
with imide (5R,6S)-5 in CH2Cl2 at –78 °C proceeded
smoothly to give the ring-opening product 14 in 68%
yield. To introduce the ethoxycarbonylmethyl group, the
TBS group in compound 14 was cleaved under acidic con-
ditions (BF3·OEt2, CH2Cl2, 0 °C) to give 15 in 92%
yield.17 The resulting alcohol 15 was oxidized with Dess–
Martin periodinane (DMP)18 to give aldehyde 4 in quanti-
tative yield (Scheme 3).
For the asymmetric carboxymethylation, an enzymatic
method,19 Evans asymmetric aldol-type reaction,20 and
Brown’s asymmetric allylation reaction21 were all plausi-
ble. We sought to use Evans’ aldol chemistry in view of
its excellent enantio- and diastereoselectivities, as well as
its compatibility with different substituents that may be
useful for the synthesis of analogues of (–)-morusimic
acid D. To take advantages of the progress in Evans aldol
chemistry,22,23 oxazolidine-2-thione derivative 17 was se-
lected for the asymmetric aldol reaction, where the chloro
atom will serve as a stereodirecting group for the asym-
metric aldol-type reaction.20 The starting oxazolidine-2-
thione 16 was prepared in 91% yield by the method re-
ported by Wu.24 Successive treatment of oxazolidine-2-
thione 16 with n-butyllithium and chloroacetyl chloride
gave 17 in 85% yield. Asymmetric aldol reaction of 4 with
17 under Crimmins’ conditions [TiCl4, (i-Pr)2EtN, N-
methylpyrrolidin-2-one (NMP), CH2Cl2, 0 °C]23 provided
18 as the only isolable diastereomer in 70% yield
(Scheme 4).
Scheme 4
The subsequent steps required for the synthesis of moru-
simic acid D (2) included N-Boc deprotection, one-pot re-
ductive cyclization–debenzylation, dechlorination, and
cleavage of the chiral auxiliary. Attempts to cleave the
protecting group Boc by TFA, followed by Pd(OH)2 or
Pd/C-catalyzed hydrogenolysis to obtain 19 was unsuc-
cessful, and other attempts under the conditions shown in
Scheme 5 also failed.
After extensive trials, it was found that after the cleavage
of the chiral auxiliary under Evans’ conditions25 (LiOH,
H2O2, THF–H2O, 1 h) selective dechlorination could be
achieved by subjecting 20 (colorless oil, yield 92%) to
Abushanab’s hydrogenation conditions26 [H2 (l atm), 10%
Pd/C, Et3N, MeOH, 24 h, r.t.], which furnished the
dechloro product 3 in 85% yield along with 10% of the re-
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Finally, treatment of 3 with trifluoroacetic acid in dichlo-
romethane at 0 °C for one hour, followed by subjecting
the resulting crude product to catalytic hydrogenolysis
(10% Pd/C, H2, MeOH, r.t., 24 h) led, in one pot, to the
formation of morusimic acid D (2) in 75% yield as a white
powder {[a]D20 –14.0 (c 0.25, MeOH), lit.9 [a]D20 –14.6 (c
0.25, MeOH)}. The 1H NMR and 13C NMR spectral data
of the synthetic material are identical with those reported
for the natural morusimic acid D (2).9
Alternatively, morusimic acid D methyl ester (22)27 could
be obtained in one pot by treatment of 3 with trifluoroace-
tic acid, followed by catalytic hydrogenolysis in methanol
using Pearlman’s catalyst [Pd(OH)2/C (20 mol%), H2, 1
atm] for three hours, and then stirring with concentrated
hydrochloric acid for 24 hours (Scheme 7).
In summary, by modifying the reaction conditions, the
C2/C6 regioselectivity of the addition of methyl magne-
sium iodide to N,O-diprotected 3-benzyloxyglutarimide 6
was improved from 86:14 to at least 95:5. On the basis of
this reaction, the first asymmetric synthesis of (–)-moru-
simic acid D is achieved in 11 steps with an overall yield
of 13% from (R)-6, with all the three stereocenters estab-
lished in excellent diastereoselectivities.
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